In the liver, ICA activates the AMPK/PGC-1α/GLUT4 pathway to enhance fatty acid oxidation and reduce oxidative stress, which is beneficial in metabolic conditions such as fatty liver disease. This evidence concerns the gene SLC2A4 and fatty liver disease.